Search

Search Results

Found 33 items.

A case of acquired factor XIII deficiency secondary to plasmablastic lymphoma

Vincenzo Sammartano, Adele Santoni, Elisabetta Zappone, Paola Calzoni, Daniela Fineschi, Eleonora Franceschini, Federico Caroni, Anna Sicuranza, Monica Bocchia, Luca Puccetti

09-03-2023

645

PDF: 337
Venous thromboembolism prophylaxis in orthopedic surgery: a narrative review

Sarah Gallitto, Thomas C. Varkey, Jacob Lahti

13-12-2024

870

PDF: 120
A nitric oxide-donor pravastatin hybrid drug exerts antiplatelet and antiatherogenic activity in mice

Stefania Momi, Giuseppe Guglielmini, Giulia Ciarroca Taranta, Elisa Giglio, Angela Monopoli, Paolo Gresele

23-05-2022

4619

PDF: 244
Successful treatment of aortic arch mural thrombosis with low-dose, ultra-slow-flow thrombolysis: a case report and literature review

Rosina Albisinni, Tommaso Marrazzo, Arta Karruli, Sabrina Manduca, Giuseppe Nobile, Nicola Galdieri, Marisa De Feo

24-10-2022

525

PDF: 171
The Von Willebrand factor-ADAMTS-13 axis: a two-faced Janus in bleeding and thrombosis

Stefano Lancellotti, Monica Sacco, Maira Tardugno, Antonietta Ferretti, Raimondo De Cristofaro

26-04-2022

1954

PDF: 332
Diagnosis and management of abnormal uterine bleeding in adolescence An expert Consensus Statement of SIGO (Italian Society of Gynecology and Obstetrics) and SISET (Italian Society for the Study of Hemostasis and Thrombosis)

Roberto Mario Santi, Annamaria Fulghesu, Ezio Zanon, Erica De Candia, Elvira Grandone, Giancarlo Di Renzo, Claudia Succu, Valentina Tosto, Vincenzina Bruni, Paolo Gresele

08-05-2024

717

PDF: 288
The evolving landscape of gene therapy for congenital severe hemophilia: a 2024 state of the art

Giovanni Di Minno, Gaia Spadarella, Ilenia Lorenza Calcaterra, Giancarlo Castaman, Paolo Simioni, Raimondo De Cristofaro, Cristina Santoro, Flora Peyvandi, Matteo Di Minno

04-09-2024

778

PDF: 172

SUPPLEMENTARY MATERIAL: 83
Long-term persistence of high anti-PF4 antibodies titer in a challenging case of AZD1222 vaccine-induced thrombotic thrombocytopenia

Luca Barcella, Chiara Ambaglio, Paolo Gritti, Francesca Schieppati, Varusca Brusegan, Eleonora Sanga, Marina Marchetti, Luca Lorini, Anna Falanga

28-06-2023

523

PDF: 171
The 2024 Nobel prize in Medicine: impact on hemostasis and thrombosis research

Loredana Bury, Marco Malvestiti, Paolo Gresele

19-11-2024

877

PDF: 204
Platelet distribution width is associated with cardiovascular mortality in an adult general population

Benedetta Izzi, Simona Costanzo, Alessandro Gialluisi, Amalia De Curtis, Sara Magnacca, Teresa Panzera, Augusto Di Castelnuovo, Maria Benedetta Donati, Chiara Cerletti, Marc F. Hoylaerts, Giovanni de Gaetano, Licia Iacoviello, *on behalf of the Moli-sani Study Investigators

27-09-2023

1514

PDF: 250

Supplementary Material: 39
Aspirin or low-molecular weight heparin for thromboprophylaxis after a fracture? That is the question

Giuseppe Camporese, Paolo Prandoni, Walter Ageno

17-05-2023

708

PDF: 357
Milvexian and other drugs targeting Factor XI: a new era of anticoagulation?

Marco P. Donadini, Walter Ageno

15-04-2022

1974

PDF: 515
The amazing genetic complexity of anucleated platelets

Loredana Bury, Paolo Gresele

15-07-2022

2065

PDF: 289
Platelet transcriptomic changes in myocardial infarction are sex and clinical subtype-related: a step forward towards precision medicine?

Loredana Bury, Alessio Branchini, Francesco Bernardi, Paolo Gresele

11-03-2025

44

PDF: 22
Iatrogenic pseudoaneurysm of inferior epigastric artery: not only a surgical complication

Rossana Corso, Andrea Coppola, Stefano Grazioli, Cristina Dedionigi, Nicolò Tandurella, Massimo Venturini, Francesco Dentali

14-07-2022

753

PDF: 174

Supplementary Video: 196
Blood platelets and Charles Darwin’s natural selection

Stefania Momi, Paolo Gresele

30-03-2023

585

PDF: 295
Commentary on “Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicenter, open-label, randomized controlled trial”

Ottavia Borghese, Claudio Vincenzoni

26-06-2024

956

PDF: 234
The night of randomized clinical trials where all patients are black: a need to estimate variability in treatment effects

Giovanni de Gaetano, Chiara Cerletti, Licia Iacoviello, Maria Benedetta Donati

22-03-2022

1755

PDF: 242
Welcome to the 12^th International Conference on Thrombosis and Hemostasis Issues in Cancer!

Anna Falanga, Benjamin Brenner, Alok A. Khorana

16-05-2024

1304

PDF: 198
Protein S on the surface of plasma lipoproteins: a potential mechanism for protein S delivery to the atherosclerotic plaques?

Marcello Baroni, Paolo Ferraresi, Nicole Ziliotto, Daria Bortolotti, Pierfilippo Acciarri, Nicola Martinelli, Giovanna Marchetti, Matteo Coen, Francesco Bernardi

17-10-2022

2047

PDF: 195
Synthetic platelets: can bioengineering realize in few years what evolution made in over 200 million years?

Paolo Gresele

24-10-2024

1748

PDF: 325
Factor XI inhibitors: a new option for the prevention and treatment of cancer-associated thrombosis

Marcello Di Nisio, Matteo Candeloro, Nicola Potere, Ettore Porreca, Jeffrey I. Weitz

16-05-2024

644

PDF: 249
The new era of anticoagulation: factor XI and XII inhibitors

Domenico Prisco, Irene Mattioli, Raffaele De Caterina, Alessandra Bettiol

07-06-2023

2023

PDF: 833
The balance between hemorrhage and thrombosis in patients surviving spontaneous intracerebral bleeding: the nightmare of a neurologist

Alessandro Pezzini

21-08-2024

1245

PDF: 331
Rationale and design of a study on D-dimer use to stratify patients after a first unprovoked venous thromboembolism for their risk of recurrence: extended low-dose Apixaban given only to patients with positive D-dimer results The Apidulcis study

Gualtiero Palareti, Paolo Prandoni, Cristina Legnani, Emilia Antonucci, Serena Zorzi, Alberto Tosetto, Lorenza Bertù, Sophie Testa, Vittorio Pengo, Walter Ageno, Ida Martinelli, Benilde Cosmi, Eugenio Bucherini, Daniela Poli

22-03-2022

988

PDF: 318

APPENDIX: 61
Artificial intelligence and machine learning in hemostasis and thrombosis

Paolo Gresele

30-12-2023

2203

PDF: 436
Unveiling the “common soil” of cardiovascular disease and cancer

Licia Iacoviello, Maria Benedetta Donati

24-02-2025

513

PDF: 159
Descriptive analysis of patients positive for anti-phospholipid antibodies included in two Italian registries

Vittorio Pengo, Luca Sarti, Emilia Antonucci, Stefania Di Agostino, Elisa Bison, Gentian Denas, Daniela Poli, Pier Luigi Meroni, Roberto Gerli, Antonella Radice, Gualtiero Palareti, on behalf of FIRMA group and START collaborators

12-10-2023

742

PDF: 203
Pathways for lower extremity superficial vein thrombosis management in an academic medical center

Gisoo Imani, Aaron Wilson, Sara Vazquez, Daniel M. Witt

24-03-2025

50

PDF: 3
It’s definitely time to consider diet in its ultra-processing form as a major risk factor for thrombotic vascular disorders

Marialaura Bonaccio, Licia Iacoviello, Maria Benedetta Donati

03-08-2023

1066

PDF: 195
Moving beyond p-value

Augusto Di Castelnuovo, Licia Iacoviello

15-04-2022

2062

PDF: 411
Welcome to the 12th International Conference on Thrombosis and Hemostasis Issues in Cancer! Oral Communications and Posters

Anna Falanga, Benjamin Brenner, Alok A. Khorana

16-05-2024

339

PDF: 311
Plasma fibrinogen levels and all-cause and cause-specific mortality in an Italian adult population: results from the Moli-sani study

Roberta Parisi, Simona Costanzo, Romy de Laat-Kremers, Augusto Di Castelnuovo, Amalia De Curtis, Teresa Panzera, Mariarosaria Persichillo, Chiara Cerletti, Giovanni de Gaetano, Maria Benedetta Donati, Licia Iacoviello, Bas de Laat , for the Moli-sani Study Investigators

27-01-2023

1540

PDF: 382

APPENDIX: 73

1 - 33 of 33 items

© PAGEPress 2008-2025 • PAGEPress^® is a registered trademark property of PAGEPress srl, Italy • VAT: IT02125780185 • Privacy